LOS PACIENTES AVANZANDO EN INVESTIGACIÓN
Please note that research proposals to the Spring 2017 ‘All-Priorities’ Research Call, including the re-submission of previously unsuccessful proposals may only be made using the online grant-application system – see the ‘Submission’ section below.
PLEASE DO NOT USE OLD-STYLE WORD OR PDF APPLICATION FORMS AS IT WILL NOT BE POSSIBLE TO ACCEPT SUCH PROPOSALS FOR CONSIDERATION
Only extension requests for current research grants may be submitted offline. You will find the necessary document in the Grant Extension box on the left.
This is a one-stage process of application.
· The submission deadline for online applications is 19th April 2017.
· Research proposals must be submitted via our online system https://grants.debra-international.org/
· If you are experiencing any technical problems or your query is not answered in the information
provided in the system, please contact email@example.com.· Please read the Terms and Conditions before completing an application form.· If you are applying for an extension (one-year maximum) to an existing DEBRA research grant,
please complete the application form for grant extensions. You will find the necessary document
in the Grant Extension box on the left.
· Research Proposals will be reviewed by external reviewers and members of DEBRA
International's Medical & Scientific Advisory Panel (MSAP) on 24th September 2017.
Recommendations for funding made by MSAP at a grant review meeting will then be considered
by DEBRA's Boards of Trustees.· Subject to funding availability, allocation of funds will recognise an equal prioritisation of
the research areas, while adhering to the core principle of funding the best research, identified
by MSAP as meeting the criteria of scientific quality, feasibility and patient benefit.· The final funding decision will be at the discretion of DEBRA International. It is anticipated that
funding decisions will be made no later than November 2017.
· Improve our understanding of the biology and genetics of all forms of EB, as better
understanding can lead to new approaches to diagnose and treat EB· Work towards the development of therapies (including possible gene-therapies, cell-
therapies, drug therapies or protein therapies)· Understand the nature of wound healing and the development of skin cancer in EB, and seek
to develop better treatments and prevention strategies· Support clinical care research to improve the management of EB through symptom relief
· One of the defined priority research areas· Between 6 months and 3 years duration· It is expected that funding requests would not exceed €90K per annum; however, funding in
excess of these amounts may be allowed if considered by DEBRA to be adequately justified in
the grant application, and subject to funding availability· Currency may be USD, EUR or GBP; contracts will be issued in USD, EUR or GBP for a binding
· DEBRA International welcomes proposals for co-funding with other organisations, including
government, academia, industry or other charities.· DEBRA will not, however, fund generic technology development costs not closely related to a
specific EB therapeutic approach.· If in doubt about whether your application would be eligible, please contact Dr Clare Robinson,
DEBRA International Head of Research firstname.lastname@example.org, before
submitting a full application.